2 results
Approved WMOPending
The objective of this phase-3 randomized study, with a double-blind treatment period of 8 weeksduration is to evaluate the efficacy and safety of the fixed dose combinations of TAK-491 pluschlorthalidone (40/12.5 mg and 40/25 mg) in subjects with…
Approved WMORecruiting
The proposed multi-center population-based open-label randomized controlled trial with blinded outcome assessment will examine if metformin slows AAA growth in patients with small AAAs who do not have diabetes. Primary objective To examine if up to…